Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Change in Accured Expenses: 2017-2024

Historic Change in Accured Expenses for DiaMedica Therapeutics (DMAC) over the last 8 years, with Dec 2024 value amounting to $2.5 million.

  • DiaMedica Therapeutics' Change in Accured Expenses rose 176.69% to $227,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $226,000, marking a year-over-year decrease of 43.78%. This contributed to the annual value of $2.5 million for FY2024, which is 615.23% up from last year.
  • Per DiaMedica Therapeutics' latest filing, its Change in Accured Expenses stood at $2.5 million for FY2024, which was up 615.23% from $348,000 recorded in FY2023.
  • In the past 5 years, DiaMedica Therapeutics' Change in Accured Expenses registered a high of $2.5 million during FY2024, and its lowest value of -$266,000 during FY2020.
  • Moreover, its 3-year median value for Change in Accured Expenses was $366,000 (2022), whereas its average is $1.1 million.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first crashed by 217.70% in 2020, then surged by 771.43% in 2022.
  • Over the past 5 years, DiaMedica Therapeutics' Change in Accured Expenses (Yearly) stood at -$266,000 in 2020, then soared by 115.79% to $42,000 in 2021, then skyrocketed by 771.43% to $366,000 in 2022, then decreased by 4.92% to $348,000 in 2023, then soared by 615.23% to $2.5 million in 2024.